Since November 2020, the S&P 500 has delivered a total return of 89.1%. But one standout stock has nearly doubled the market - over the past five years, Red Rock Resorts has surged 162% to $57.01 per share. Its momentum hasn’t stopped as it’s also gained 29.6% in the last six months, beating the S&P by 10.1%. Is now the time to buy Red Rock Resorts, or should you be careful about including it in your portfolio? Get the full stock story straight from our expert analysts, it’s free for active Edge members. ...

Over the past six months, W.W. Grainger’s shares (currently trading at $952.66) have posted a disappointing 8.7% loss, well below the S&P 500’s 19.5% gain. This may have investors wondering how to approach the situation. Is there a buying opportunity in W.W. Grainger, or does it present a risk to your portfolio? Check out our in-depth research report to see what our analysts have to say, it’s free for active Edge members. Why Is W.W. Grainger Not Exciting? Even with the cheaper entry price, we're swipin ...

Lockheed Martin has been treading water for the past six months, recording a small loss of 0.7% while holding steady at $468.11. The stock also fell short of the S&P 500’s 19.5% gain during that period. Is there a buying opportunity in Lockheed Martin, or does it present a risk to your portfolio? Get the full breakdown from our expert analysts, it’s free for active Edge members. Why Do We Think Lockheed Martin Will Underperform? We're cautious about Lockheed Martin. Here are three reasons we avoid LMT a ...

Core Insights - Aspen Aerogels reported a revenue of $73.02 million for the quarter ended September 2025, reflecting a year-over-year decline of 37.8% and an EPS of -$0.06 compared to $0.11 a year ago [1] - The reported revenue fell short of the Zacks Consensus Estimate of $74.39 million, resulting in a surprise of -1.85% [1] - The company did not deliver an EPS surprise, with the consensus EPS estimate being $0 [1] Financial Performance Metrics - Revenue from the Energy Industrial segment was $24.3 million, below the estimated $26.48 million, representing a year-over-year decline of 9.3% [4] - Revenue from the Thermal Barrier segment was $48.7 million, exceeding the estimated $46.81 million, but showing a significant year-over-year decline of 46.3% [4] - Gross Profit for the Thermal Barrier segment was reported at $11.93 million, lower than the estimated $15.15 million, while Gross Profit for the Energy Industrial segment was $8.87 million, also below the estimated $9.49 million [4] Stock Performance - Aspen Aerogels' shares have returned -10.8% over the past month, contrasting with the Zacks S&P 500 composite's increase of +1.3% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

While the S&P 500 is up 19.5% since May 2025, Origin Bancorp (currently trading at $35.14 per share) has lagged behind, posting a return of 8.8%. This may have investors wondering how to approach the situation. Does this present a buying opportunity for OBK? Or does the price properly account for its business quality and fundamentals? Why Does OBK Stock Spark Debate? Founded in 1912 during the early boom days of Louisiana banking, Origin Bancorp (NYSE:OBK) is a financial holding company that provides pe ...

Group 1 - The article does not provide any relevant content regarding company or industry insights [1]

While the S&P 500 is up 19.5% since May 2025, Ross Stores (currently trading at $160.23 per share) has lagged behind, posting a return of 12%. This may have investors wondering how to approach the situation. Given the relatively weaker price action, is now a good time to buy ROST? Or are investors better off allocating their money elsewhere? Why Does ROST Stock Spark Debate? Selling excess inventory or overstocked items from other retailers, Ross Stores (NASDAQ:ROST) is an off-price concept that sells a ...

Core Insights - The article emphasizes the importance of staying updated on stocks within the biotech, pharma, and healthcare sectors, highlighting key trends and catalysts that influence market valuations [1]. Group 1: Industry Overview - The biotech, pharma, and healthcare industries are experiencing significant movements, necessitating investors to track developments closely [1]. - The Haggerston BioHealth investing group provides insights into catalysts for investment decisions, including buy and sell ratings, product sales forecasts, and financial analyses [1]. Group 2: Analyst Background - Edmund Ingham, a biotech consultant with over 5 years of experience, has compiled detailed reports on more than 1,000 companies in the biotech and healthcare sectors [1]. - The investing group led by Ingham caters to both novice and experienced investors, offering comprehensive market analyses and forecasts [1].

Core Insights - The article emphasizes the importance of staying updated on stocks within the biotech, pharma, and healthcare sectors, highlighting key trends and catalysts that influence market valuations [1]. Group 1: Industry Overview - The biotech, pharma, and healthcare industries are experiencing significant movements, necessitating investors to track developments closely [1]. - The Haggerston BioHealth investing group provides insights into catalysts for investment decisions, including buy and sell ratings, product sales forecasts, and financial analyses [1]. Group 2: Analyst Background - Edmund Ingham, a biotech consultant with over five years of experience, has compiled detailed reports on more than 1,000 companies in the sector [1]. - The investing group led by Ingham caters to both novice and experienced investors, offering comprehensive market analyses and forecasts [1].

Core Insights - Apple's streaming service, Apple TV, experienced an outage affecting nearly 14,907 users in the U.S. on Thursday [1] Group 1 - The outage was tracked by Downdetector.com, indicating a significant disruption in service for Apple TV users [1]